Keros Therapeutics, Inc. (NASDAQ: KROS) is a clinical-stage biopharmaceutical company making waves in the biotechnology industry. With a focus on innovative therapeutics targeting dysfunctional signaling of the transforming growth factor-beta..
Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is capturing the attention of investors in the biotechnology sector with its promising pipeline of therapies aimed at tackling severe autoimmune diseases. As a clinical-stage..
AMN Healthcare Services Inc (NYSE: AMN) is making waves in the healthcare sector with a remarkable 99.9% revenue growth, positioning itself as a significant player in the medical care facilities..
Kura Oncology, Inc. (NASDAQ: KURA), a prominent player in the biotechnology industry, is drawing attention with a market capitalization of $826.49 million. With its focus on developing innovative treatments for..
Evolus, Inc. (NASDAQ: EOLS), a dynamic player in the healthcare sector, is capturing investor attention with its promising potential for substantial gains. Operating within the specialty and generic drug manufacturing..
Investors interested in the healthcare sector, particularly in medical distribution, may want to keep an eye on Akso Health Group (AHG). Headquartered in Qingdao, China, this company operates within the..
CareDx, Inc. (CDNA), a prominent player in the healthcare sector specializing in diagnostics and research, has been making waves with its innovative solutions aimed at improving transplant patient outcomes. Headquartered..
Oculis Holding AG (NASDAQ: OCS) is capturing the attention of investors with a staggering potential upside of 234.52%, according to the average analyst target price of $37.50. As a clinical-stage..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company, is making waves in the healthcare sector with its cutting-edge immunology therapeutics. Based in San Diego, California, AnaptysBio focuses on developing innovative..
Geron Corporation (NASDAQ: GERN), a biopharmaceutical company specializing in oncology therapeutics, is drawing significant attention from investors due to its promising pipeline and notable potential upside. With a current market..
Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents an intriguing investment opportunity within the healthcare sector, specifically in the niche of drug manufacturers focusing on specialty and generic solutions. With a current..
Taysha Gene Therapies, Inc. (TSHA) is making waves in the biotechnology sector with its ambitious focus on developing adeno-associated virus-based gene therapies for severe monogenic diseases of the central nervous..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) presents an intriguing case for investors exploring opportunities in the biotechnology sector. With a market capitalization of $1.44 billion, this U.S.-based company has carved out..
CeriBell, Inc. (NASDAQ: CBLL), a dynamic player in the healthcare sector, is capturing investor attention with a potential upside of 52.25% based on analyst price targets. This Sunnyvale, California-based company..
RxSight, Inc. (NASDAQ: RXST) is carving out a niche in the healthcare sector with its innovative approach to cataract surgery, offering investors a unique opportunity to capitalize on groundbreaking technology..
HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the health information services industry, offers a suite of Software-as-a-Service (SaaS) applications tailored for healthcare organizations. With a market cap of $823.87..
Iovance Biotherapeutics, Inc. (IOVA), a prominent player in the biotechnology sector, is capturing the attention of investors with its potential for significant upside. With a market capitalization of $2.09 billion,..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company, is gaining significant attention in the investor community with an enticing potential upside of 42.29% based on its current trading price..
Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Tübingen, Germany, is capturing the attention of investors with its groundbreaking work in the field of T cell redirecting immunotherapies..
